Year archive

ACRUX LIMITED — 2024 filings

All 55 regulatory filings released by ACRUX LIMITED (ACR) in 2024, sourced directly from the official regulator.

55 Filings

2024 Period

2024 filings (55)

Filing	Released	Lang
Acrux raises $1.34 million from SPP 1 page 120.7KB Capital/Financing Update	2024-12-22	English
Application for quotation of securities - ACR 6 pages 18.2KB Share Issue/Capital Change	2024-12-22	English
Cleansing Notice 1 page 141.7KB Capital/Financing Update	2024-12-22	English
Application for quotation of securities - ACR 6 pages 18.4KB Share Issue/Capital Change	2024-12-18	English
Cleansing Notice 1 page 141.8KB Capital/Financing Update	2024-12-18	English
Change in substantial holding 2 pages 132.4KB Major Shareholding Notification	2024-12-18	English
Investor Deck update, SPP Closes 18 December 2024, 5pm 22 pages 2.2MB Investor Presentation	2024-12-16	English
Investor Webinar, Tuesday 17 December 2024 4pm AEDT 2 pages 133.2KB Investor Presentation	2024-12-15	English
Commercialisation of Nitroglycerin Ointment 2 pages 168.8KB Regulatory Filings	2024-12-12	English
Notification regarding unquoted securities - ACR 6 pages 19.2KB Share Issue/Capital Change	2024-12-11	English
Application for quotation of securities - ACR 5 pages 16.6KB Share Issue/Capital Change	2024-12-11	English
Cleansing Notice 1 page 140.8KB Regulatory Filings	2024-12-11	English
Appendix 3Y - Brumley 2 pages 256.7KB Director's Dealing	2024-12-11	English
Appendix 3Y Brooke 2 pages 207.8KB Director's Dealing	2024-12-11	English
Appendix 3Y - Dobinson 2 pages 194.3KB Director's Dealing	2024-12-11	English
Appendix 3Y - Oldham 2 pages 257.4KB Director's Dealing	2024-12-11	English
Notification of cessation of securities - ACR 4 pages 14.6KB Transaction in Own Shares	2024-12-11	English
Application for quotation of securities - ACR 6 pages 18.3KB Share Issue/Capital Change	2024-12-11	English
Cleansing Notice 2 pages 143.5KB Capital/Financing Update	2024-12-11	English
Share Purchase Plan Offer Booklet 18 pages 466.3KB Capital/Financing Update	2024-12-05	English
Share Placement successfully concluded and SPP launched 4 pages 194.6KB Capital/Financing Update	2024-12-04	English
Proposed issue of securities - ACR 5 pages 19.0KB Capital/Financing Update	2024-12-04	English
Proposed issue of securities - ACR 6 pages 20.3KB Capital/Financing Update	2024-12-04	English
Proposed issue of securities - ACR 5 pages 19.1KB Capital/Financing Update	2024-12-04	English
Investor Presentation 23 pages 2.2MB Investor Presentation	2024-12-04	English
Cleansing Notice 1 page 144.6KB Capital/Financing Update	2024-12-04	English
FDA Approval - Nitroglycerin Ointment 2 pages 163.9KB Regulatory Filings	2024-12-03	English
Trading Halt 2 pages 209.3KB Capital/Financing Update	2024-12-02	English
AGM Presentation 22 pages 2.9MB AGM Information	2024-11-20	English
Results of Meeting 2 pages 188.3KB Declaration of Voting Results & Voting Rights Announcements	2024-11-20	English
Quarterly Activities/Appendix 4C Cash Flow Report 8 pages 427.1KB Interim / Quarterly Report	2024-10-30	English
Notice of Annual General Meeting/Proxy Form 15 pages 762.9KB AGM Information	2024-10-14	English
FY24 R&D Tax Incentive rebate received 1 page 125.1 Capital/Financing Update	2024-10-01	English
ASX Small and Mid Cap Conference presentation 19 pages 1.6MB Investor Presentation	2024-09-23	English
Appendix 4E and FY24 Full Year Statutory Accounts 70 pages 14.2MB Annual Report	2024-08-28	English
Appendix 4G and Corporate Governance Statement FY24 27 pages 696.8KB Governance Information	2024-08-28	English
FY24 Full Year Results - Investor Presentation 13 pages 1.1MB Investor Presentation	2024-08-28	English
Investor Webinar Information - FY24 Results 2 pages 106.2KB Investor Presentation	2024-08-28	English
FDA Approval received for Dapsone Gel, 7.5% 2 pages 164.3KB Capital/Financing Update	2024-08-26	English
Quarterly Activities Report and Appendix 4C - June 2024 9 pages 422.2KB Interim / Quarterly Report	2024-07-25	English
Acrux presentation to Bioshares, 18th Biotech Summit 14 pages 1.4MB Investor Presentation	2024-07-14	English
RDTI funding facility secured 1 page 125.2KB Capital/Financing Update	2024-06-27	English
Acrux presentation at Hidden Gems in Lifesciences Forum 14 pages 1.2MB Investor Presentation	2024-06-12	English
Quarterly Activities/Appendix 4C Cash Flow Report 9 pages 481.1KB Interim / Quarterly Report	2024-04-29	English
Quarterly Activities and Appendix 4C, reissued 10 pages 506.2KB Interim / Quarterly Report	2024-04-29	English
Launch of Dapsone 5%, Gel in the United States 1 pa Capital/Financing Update	2024-04-02	English
Application for quotation of securities - ACR 5 pages 16.7KB Share Issue/Capital Change	2024-03-04	English
Appendix 3Y Brumley 2 pages 235.4KB Director's Dealing	2024-03-04	English
Appendix 3Y Dobinson 2 pages 194.3KB Director's Dealing	2024-03-04	English
Appendix 4D and Half Year Accounts 19 pages 824.6KB Interim / Quarterly Report	2024-02-26	English
Investor Presentation Half Year Accounts 11 pages 776.8KB Investor Presentation	2024-02-26	English
Investor Webinar Details - Financial Results 1H FY24 2 pages 134.2KB Investor Presentation	2024-02-22	English
Notification regarding unquoted securities - ACR 6 pages 18.4KB Share Issue/Capital Change	2024-02-13	English
Application for quotation of securities - ACR 7 pages 19.6KB Share Issue/Capital Change	2024-02-13	English
Appendix 4C and Activities Statement 9 pages 303.0KB Interim / Quarterly Report	2024-01-30	English

Filings by year

2026 12 filings
2025 71 filings
2024 55 filings
2023 49 filings
2022 49 filings
2021 63 filings
2020 49 filings
2019 33 filings
2018 25 filings
2017 30 filings
2016 36 filings
2015 38 filings
2014 60 filings
2013 65 filings
2012 52 filings
2011 41 filings
2010 48 filings
2009 49 filings
2008 53 filings
2007 99 filings
2006 58 filings
2005 68 filings
2004 44 filings